NeoImmuneTech obtains approval for phase 2 trial of brain tumor treatment from US FDA

May 12, 2022

Seoul [South Korea], May 12 (ANI/Global Economic): NeoImmuneTech said on the 11th that it has obtained the approval for a phase 2 clinical trial...